FDA warns telehealth companies over compounded GLP-1s

June 17, 2026 01:15 PM EDT PharmaHealth Tech FDA warns tele­health com­pa­nies over com­pound­ed GLP-1s Shelby Livingston Health tech correspondent The FDA has is­sued a new batch of warn­ing let­ters to 25 tele­health com­pa­nies, ac­cus­ing them of mak­ing false and mis­lead­ing claims in their mar­ket­ing … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER